journal
https://read.qxmd.com/read/38814635/immunotherapy-for-a-choroidal-pigmented-lesion
#41
JOURNAL ARTICLE
Selin Orge, Almila Sarigul Sezenoz, Hakan Demirci
No abstract text is available yet for this article.
May 30, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38814626/syfovre-approval-for-geographic-atrophy
#42
JOURNAL ARTICLE
Charles C Wykoff, Eleonora M Lad, Jeffrey S Heier
No abstract text is available yet for this article.
May 30, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38814618/systemic-fluoroquinolone-use-and-risk-of-uveitis-or-retinal-detachment
#43
JOURNAL ARTICLE
Jeremy P Brown, Kevin Wing, Stephen J Evans, Clémence Leyrat, Kathryn E Mansfield, Liam Smeeth, Angel Y S Wong, David Yorston, Nicholas W Galwey, Ian J Douglas
IMPORTANCE: Fluoroquinolone use has been associated with increased risk of uveitis and retinal detachment in noninterventional studies, but the findings have been conflicting and causality is unclear. OBJECTIVE: To estimate the association of systemic fluoroquinolone use with acute uveitis or retinal detachment, using multiple analyses and multiple databases to increase the robustness of results. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from the Clinical Practice Research Datalink Aurum and GOLD UK primary care records databases, which were linked to hospital admissions data...
May 30, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38814580/does-systemic-fluoroquinolone-use-increase-risk-of-retinal-detachment
#44
JOURNAL ARTICLE
Su-Hsun Liu, Barbara S Hawkins
No abstract text is available yet for this article.
May 30, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38814578/potential-medicare-part-d-savings-on-ophthalmic-generic-drugs
#45
JOURNAL ARTICLE
David A Collet, Matthew B Urban, Abha Amin
No abstract text is available yet for this article.
May 30, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38780937/interventions-for-proliferative-vitreoretinopathy
#46
JOURNAL ARTICLE
Wilson X Wang, Maggie Xing, Rajendra S Apte
CLINICAL QUESTION: What is the efficacy of pharmacologic interventions in preventing proliferative vitreoretinopathy? BOTTOM LINE: There is limited high-quality evidence to support currently available pharmacological options for prevention of proliferative vitreoretinopathy.
May 23, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38780931/effect-of-low-dose-aspirin-on-the-course-of-age-related-macular-degeneration-a-secondary-analysis-of-the-aspree-randomized-clinical-trial
#47
JOURNAL ARTICLE
Liubov D Robman, Rory Wolfe, Robyn L Woods, Le Thi Phuong Thao, Galina A Makeyeva, Lauren A B Hodgson, Y-Anh Lepham, Kim Jachno, James Phung, Emily Maguire, Henry Luong, Ruth E Trevaks, Stephanie A Ward, Sharyn M Fitzgerald, Suzanne G Orchard, Paul Lacaze, Elsdon Storey, Walter P Abhayaratna, Mark R Nelson, Robyn H Guymer, John J McNeil
IMPORTANCE: Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in old age. There is no proven intervention to prevent AMD and, apart from lifestyle, nutritional, and supplement advice, there is no intervention to delay its progression. OBJECTIVE: To determine the impact of long-term low-dose aspirin on the incidence and progression of AMD. DESIGN, SETTING AND PARTICIPANTS: The Aspirin in Reducing Events in the Elderly-AMD (ASPREE-AMD) study was an Australian-based substudy of the ASPREE trial, a multicenter, international, randomized, double-masked, placebo-clinical trial investigating the efficacy of low-dose aspirin in prolonging disability-free survival among older individuals...
May 23, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38780928/episodic-upper-eyelid-edema-in-an-african-american-patient
#48
JOURNAL ARTICLE
Sruti S Akella, Sudarshan Srivatsan, Amy Lin
No abstract text is available yet for this article.
May 23, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38753350/%C3%AF-3-fatty-acid-supplements-may-not-improve-dry-eye-symptoms
#49
JOURNAL ARTICLE
Ian J Saldanha
No abstract text is available yet for this article.
May 16, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38753338/nationwide-prevalence-of-inherited-retinal-diseases-in-the-israeli-population
#50
JOURNAL ARTICLE
Sapir Shalom, Tamar Ben-Yosef, Ifat Sher, Amir Zag, Ygal Rotenstreich, Tomer Poleg, Ohad S Birk, Libe Gradstein, Miriam Ehrenberg, Iris Deitch, Eedy Mezer, Idan Hecht, Eran Pras, Dan Ramon, Samer Khateb, Dinah Zur, Hadas Newman, Rawan Kharouba, Nitza Goldenberg-Cohen, Rina Leibu, Shiri Soudry, Ido Perlman, Eyal Banin, Dror Sharon
IMPORTANCE: Data regarding the prevalence of various inherited retinal diseases (IRDs) are limited and vary across populations; moreover, nationwide prevalence studies may be limited to a specific IRD phenotype, potentially leading to inaccurate prevalence estimations. Therefore, nationwide prevalence data are needed. OBJECTIVE: To determine the prevalence of 67 IRD phenotypes in the Israeli population. DESIGN, SETTING, AND PARTICIPANTS: This cohort study collected nationwide data regarding the number of individuals affected with IRD phenotypes assessed in 10 clinical and academic centers in Israel as part of the research activity of the Israeli inherited retinal disease consortium...
May 16, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38753336/re-esterified-triglyceride-%C3%AF-3-fatty-acids-in-dry-eye-disease-with-meibomian-gland-dysfunction-a-randomized-clinical-trial
#51
JOURNAL ARTICLE
Youngsub Eom, Ikhyun Jun, Hyun Sun Jeon, Dong Hui Lim, Hun Lee, Ho Sik Hwang, So-Hyang Chung, Tae-Young Chung, Jae Yong Kim, Sun Woong Kim, Chul Young Choi, Jong Suk Song, Mee Kum Kim, Kyoung Yul Seo, Joon Young Hyon
IMPORTANCE: Taking ω-3 supplements has been associated with a reduction in symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD). However, a recent relatively large clinical trial concluded that treating DED with ω-3 consumption was ineffective, potentially warranting additional investigations. OBJECTIVES: To investigate the effect of re-esterified triglyceride (rTG) ω-3 fatty acid supplementation on DED associated with MGD...
May 16, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38753324/treatment-of-vernal-keratoconjunctivitis-using-upadacitinib
#52
JOURNAL ARTICLE
Kazuhiro Kito, Ken Fukuda, Tatsuma Kishimoto, Kenji Yamashiro, Akiko Yagami
No abstract text is available yet for this article.
May 16, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38753323/tissue-loss-during-eye-bank-processing
#53
JOURNAL ARTICLE
Andrea Naranjo, Jameson Clover, Winston Chamberlain, Christopher G Stoeger, Charles C Lin, Jennifer Rose-Nussbaumer
No abstract text is available yet for this article.
May 16, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38722653/acetylcholinesterase-inhibitors-amd-and-alzheimer-disease
#54
JOURNAL ARTICLE
Yu-Hung Chen, Chen Wang, Tobias Kurth
No abstract text is available yet for this article.
May 9, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38722647/health-span-vs-lifespan-in-geographic-atrophy
#55
JOURNAL ARTICLE
Richard F Spaide, Demetrios G Vavvas
No abstract text is available yet for this article.
May 9, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38722644/pegcetacoplan-treatment-and-consensus-features-of-geographic-atrophy-over-24-months
#56
JOURNAL ARTICLE
Dun Jack Fu, Pallavi Bagga, Gunjan Naik, Sophie Glinton, Livia Faes, Bart Liefers, Rosana Lima, Georgina Wignall, Pearse A Keane, Estelle Ioannidou, Ana Paula Ribeiro Reis, Alex McKeown, Lukas Scheibler, Praveen J Patel, Ismail Moghul, Nikolas Pontikos, Konstantinos Balaskas
IMPORTANCE: Despite widespread availability and consensus on its advantages for detailed imaging of geographic atrophy (GA), spectral-domain optical coherence tomography (SD-OCT) might benefit from automated quantitative OCT analyses in GA diagnosis, monitoring, and reporting of its landmark clinical trials. OBJECTIVE: To analyze the association between pegcetacoplan and consensus GA SD-OCT end points. DESIGN, SETTING, AND PARTICIPANTS: This was a post hoc analysis of 11 614 SD-OCT volumes from 936 of the 1258 participants in 2 parallel phase 3 studies, the Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OAKS) and Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (DERBY)...
May 9, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38722622/acetylcholinesterase-inhibitors-amd-and-alzheimer-disease-reply
#57
JOURNAL ARTICLE
Joseph Magagnoli, S Scott Sutton, Jayakrishna Ambati
No abstract text is available yet for this article.
May 9, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38722614/adopting-more-precise-metrics-to-move-everyone-closer-to-eye-health
#58
JOURNAL ARTICLE
Ahmara G Ross, Eve J Higginbotham
No abstract text is available yet for this article.
May 9, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38696209/acute-corneal-edema-in-a-middle-aged-patient
#59
JOURNAL ARTICLE
Jennifer A Tran, Aaron R Kaufman, Joseph B Ciolino
No abstract text is available yet for this article.
May 2, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38696206/photokeratitis-in-outdoor-event-participants-exposed-to-uv-radiation-display
#60
JOURNAL ARTICLE
Julia Y Y Chan, Vanissa W S Chow, Carmen K M Chan, Edmund Y M Chan, James S K Lau, Timothy Y Y Lai, Alvin L Young, Clement C Y Tham
IMPORTANCE: While UV radiation displays may be used for recreational purposes at outdoor events, unprotected eyes have been reported to have symptoms consistent with photokeratitis. Such symptoms warrant documentation and evaluation in ophthalmic peer reviewed literature. OBJECTIVE: To describe a case series of photokeratitis associated with a single ultraviolet radiation display at an outdoor event. DESIGN, SETTING, AND PARTICIPANTS: This case series involved a retrospective record review of 8 patients who presented in public and private health sectors in November 2023 after developing photokeratitis following UV radiation exposure at an outdoor event in Hong Kong on the night of November 4, 2023...
May 2, 2024: JAMA Ophthalmology
journal
journal
44130
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.